Chong Kun Dang Holdings (XKRX:001630) Interest Expense : ₩-20,363 Mil (TTM As of Mar. 2024)

View and export this data going back to 1976. Start your Free Trial

What is Chong Kun Dang Holdings Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Chong Kun Dang Holdings's interest expense for the three months ended in Mar. 2024 was ₩ -5,181 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-20,363 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Chong Kun Dang Holdings's Operating Income for the three months ended in Mar. 2024 was ₩ 12,525 Mil. Chong Kun Dang Holdings's Interest Expense for the three months ended in Mar. 2024 was ₩ -5,181 Mil. Chong Kun Dang Holdings's Interest Coverage for the quarter that ended in Mar. 2024 was 2.42. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Chong Kun Dang Holdings Interest Expense Historical Data

The historical data trend for Chong Kun Dang Holdings's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chong Kun Dang Holdings Interest Expense Chart

Chong Kun Dang Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-2,947.96

-3,480.09

-4,360.45

-10,803.26

-19,603.06

Chong Kun Dang Holdings Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-4,421.41	-5,084.84	-4,889.09	-5,207.71	-5,181.41

Chong Kun Dang Holdings Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-20,363 Mil.

Chong Kun Dang Holdings (XKRX:001630) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Chong Kun Dang Holdings's Interest Expense for the three months ended in Mar. 2024 was ₩-5,181 Mil. Its Operating Income for the three months ended in Mar. 2024 was ₩12,525 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was ₩70,735 Mil.

Chong Kun Dang Holdings's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2024 )	/	Interest Expense (Q: Mar. 2024 )
	=	-1	*	12525.091	/	-5181.409
	=	2.42

The higher the ratio, the stronger the company's financial strength is.

Chong Kun Dang Holdings (XKRX:001630) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chong Kun Dang Holdings Corp (XKRX:001630) » Definitions » Interest Expense

Traded in Other Exchanges

N/A

Address

368, 3-ga, Choongjungro, Suhdaemoon-gu, Seoul, KOR, 120-756

Website

http://www.ckdpharm.com

Chong Kun Dang Holdings Corp manufactures and markets medicines and active pharmaceutical ingredients. It offers prescription drugs; over-the-counter pharmaceutical products; health supplements and consumer health products. Geographically activities are functioned through the region of South Korea.

Chong Kun Dang Holdings (XKRX:001630) Headlines

No Headlines